Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People's Republic of China and internationally. It offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. The company's peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as covers hemodialysis access, arterial, venous, peripheral embolization intervention, and other intervention products. In addition, the company provides technical consultation and services, as well as imports materials. It serves patients and physicians. The company was formerly known as Zhejiang Zylox Medical Device Co., Ltd. and changed its name to Zylox-Tonbridge Medical Technology Co., Ltd. in March 2021. Zylox-Tonbridge Medical Technology Co., Ltd. was incorporated in 2012 and is headquartered in Hangzhou, the People's Republic of China.
Frequently asked questions
What sector does Zylox-Tonbridge Med Tech Co (2190) operate in?
Zylox-Tonbridge Med Tech Co belongs to the Healthcare sector and operates in the Medical Devices industry.
What is Zylox-Tonbridge Med Tech Co (2190) current stock price?
As of the latest data, Zylox-Tonbridge Med Tech Co stock price is HK$21.10, with a previous close of HK$20.92. Zylox-Tonbridge Med Tech Co gained HK$0.18 in the last trading session, representing a 0.86% increase.
What is Zylox-Tonbridge Med Tech Co (2190) current market capitalization?
Zylox-Tonbridge Med Tech Co market cap is approximately 6.81 billion.
What is Zylox-Tonbridge Med Tech Co (2190) EBITDA?
Zylox-Tonbridge Med Tech Co EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 191.95 million.
Does Zylox-Tonbridge Med Tech Co (2190) pay dividends?
Yes. Zylox-Tonbridge Med Tech Co pays annual dividends with an annualized yield of 1.19% and an estimated annual payout of HK$0.25 per share.
When is the next ex-dividend date for Zylox-Tonbridge Med Tech Co (2190)?
The next ex-dividend date is scheduled for May 27, 2027.
What is Zylox-Tonbridge Med Tech Co (2190) beta (volatility) score?
Zylox-Tonbridge Med Tech Co has a beta of 0.307, indicating lower volatility than the overall market.